Get the Stockscreener App
14.71
4.10%
0.58
After Hours:
14.71
Xencor Inc stock is traded at $14.71, with a volume of 1.20M.
It is up +4.10% in the last 24 hours and up +25.40% over the past month.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
See More
Previous Close:
$14.13
Open:
$14.13
24h Volume:
1.20M
Relative Volume:
1.06
Market Cap:
$1.05B
Revenue:
$133.62M
Net Income/Loss:
$-177.37M
P/E Ratio:
-5.09
EPS:
-2.89
Net Cash Flow:
$23.50M
1W Performance:
+11.36%
1M Performance:
+25.40%
6M Performance:
+33.48%
1Y Performance:
-29.99%
1-Day Range:
$13.80
$14.85
1-Week Range:
$13.50
$15.50
52-Week Range:
$6.92
$27.24
Xencor Inc Stock (XNCR) Company Profile
Name
Xencor Inc
Sector
Industry
Phone
626-305-5900
Address
465 N. HALSTEAD ST., PASADENA, CA
Compare XNCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
14.71 | 1.01B | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-29-25 | Upgrade | Barclays | Underweight → Overweight |
| Sep-17-25 | Resumed | Barclays | Underweight |
| Sep-03-25 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-21-25 | Initiated | William Blair | Outperform |
| Dec-12-24 | Initiated | Wells Fargo | Overweight |
| Dec-02-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-16-24 | Reiterated | BTIG Research | Buy |
| Feb-28-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-19-23 | Initiated | BofA Securities | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Oct-13-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-21-22 | Initiated | JP Morgan | Overweight |
| Jul-06-22 | Resumed | Canaccord Genuity | Buy |
| Feb-11-22 | Initiated | BMO Capital Markets | Outperform |
| Jan-21-22 | Initiated | SMBC Nikko | Outperform |
| Dec-15-21 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Feb-24-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-04-20 | Initiated | Barclays | Underweight |
| Feb-25-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jan-30-20 | Initiated | RBC Capital Mkts | Outperform |
| Nov-20-19 | Resumed | Guggenheim | Neutral |
| Aug-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-13-19 | Initiated | Mizuho | Buy |
| Apr-12-19 | Initiated | Guggenheim | Buy |
| Mar-27-19 | Initiated | Berenberg | Buy |
| Mar-15-19 | Initiated | Raymond James | Outperform |
| Sep-10-18 | Resumed | BTIG Research | Buy |
| Mar-28-18 | Resumed | Leerink Partners | Outperform |
| Mar-02-17 | Initiated | Instinet | Neutral |
| Mar-02-17 | Reiterated | Wedbush | Outperform |
| Oct-04-16 | Initiated | Piper Jaffray | Overweight |
| Dec-22-15 | Initiated | Canaccord Genuity | Buy |
| Aug-05-15 | Reiterated | MLV & Co | Buy |
| Feb-12-15 | Reiterated | Oppenheimer | Outperform |
| Jan-28-15 | Reiterated | MLV & Co | Buy |
| Jul-11-14 | Initiated | Oppenheimer | Outperform |
View All
Xencor Inc Stock (XNCR) Latest News
Should you hold or exit Xencor Inc. nowEarnings Growth Report & Reliable Volume Spike Trade Alerts - newser.com
Will Xencor Inc. (XE9) stock return to pre crash levels2025 AllTime Highs & Detailed Earnings Play Strategies - newser.com
Tools to assess Xencor Inc.’s risk profileJuly 2025 Trends & Stepwise Trade Signal Guides - newser.com
Why Xencor Inc. stock remains on buy listsQuarterly Portfolio Summary & Community Consensus Trade Alerts - newser.com
Xencor Inc. stock trend forecastMarket Weekly Review & Daily Growth Stock Investment Tips - newser.com
Tick level data insight on Xencor Inc. volatilityJuly 2025 Decliners & Low Risk High Reward Ideas - newser.com
How Xencor Inc. stock compares to growth peers2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Why institutional investors increase stakes in Xencor Inc. (XE9) stockJuly 2025 Drop Watch & Daily Profit Maximizing Trade Tips - newser.com
Xencor Inc. stock chart pattern explainedGlobal Markets & Reliable Intraday Trade Plans - newser.com
Xencor, Inc. (XNCR) Stock forecasts - Yahoo! Finance UK
Xencor, Inc. (XNCR) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Xencor, Inc. (XNCR) stock forecast and price target - Yahoo! Finance UK
Xencor upgraded to Overweight from Underweight at Barclays - MSN
Is Xencor Inc. stock gaining market shareQuarterly Portfolio Report & Stepwise Trade Signal Implementation - newser.com
Can Xencor Inc. stock continue upward trendQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com
Xencor Earns Relative Strength Rating Upgrade; Hits Key Benchmark - MSN
Why Xencor Inc. stock is favored by pension fundsJuly 2025 Update & Consistent Return Strategy Ideas - newser.com
Xencor Inc expected to post a loss of 69 cents a shareEarnings Preview - TradingView
How Xencor Inc. (XE9) stock benefits from digital adoptionJuly 2025 Volume & Verified High Yield Trade Plans - newser.com
Will Xencor Inc. stock split again soonEarnings Growth Summary & Daily Technical Forecast Reports - newser.com
Is Xencor Inc. (XE9) stock nearing a technical breakoutEarnings Risk Summary & Technical Buy Zone Confirmation - newser.com
What to expect from Xencor Inc. in the next 30 daysJuly 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
Forecasting Xencor Inc. price range with options data2025 Earnings Surprises & Daily Technical Stock Forecast Reports - newser.com
What candlestick patterns are forming on Xencor Inc.July 2025 Closing Moves & Real-Time Buy Zone Alerts - newser.com
Xencor Inc. stock prediction for this weekJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - newser.com
Is Xencor Inc. (XE9) stock supported by free cash flowQuarterly Performance Summary & Low Risk High Win Rate Picks - newser.com
Why analysts remain bullish on Xencor Inc. stockJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
Can a trend reversal in Xencor Inc. lead to recoveryPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Xencor (NASDAQ:XNCR) Shares Gap UpHere's Why - MarketBeat
Xencor, Inc. (XNCR) Stock Forecasts - Yahoo Finance
Xencor’s Promising NSCLC Study: A Potential Game-Changer? - MSN
Xencor Inc Stock (XNCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):